Shimadzu Corporation has established a subsidiary in Mexico and has begun its activities. To date, in Mexico, analytical and measuring instruments are distributed by a subsidiary in the United States, while medical systems are marketed through a subsidiary in Brazil. The establishment of Shimadzu México, S. A. de C.V. (SMX) in the capital, Mexico City, […]
Shimadzu Corporation has invested in Symbiobe Inc. (Symbiobe), through its Corporate Venture Capital (CVC) fund, “Shimadzu Future Innovation Fund” (Shimadzu FIF). Symbiobe is a startup originating from Kyoto University that develops carbon dioxide and nitrogen fixation technology using photosynthetic organisms*. Founded in 2021, Symbiobe aims to solve social issues such as climate change and resource […]
Advancing structural biology research with the GenNext AutoFox® Protein Footprinting System and Agilent 6560 Ion Mobility Quadrupole Time-of-Flight (IM-QTOF) LC/MS system Caption: GenNext and Agilent announced a pioneering collaboration for structural biology research. Half Moon Bay, CA – Today at CASSSS 2024, GenNext Technologies and Agilent announced a pioneering collaboration that promises to transform structural […]
In 2024, Shimadzu Corporation started SPARK* (hereinafter, “this system”), a system to support employees acquiring doctorates by encouraging both their doctoral studies and routine work activities. This system supports the acquisition of university degrees by those interested in obtaining a doctorate where their domain of research from a work strategy perspective fits with the theme of […]
Tewksbury, MA – Cambridge Isotope Laboratories, Inc. (CIL), the global leader in 13C and 13C urea production, is excited to announce the startup of its North Star project, significantly increasing the company’s production capabilities. The North Star project commenced in mid-2020 as the world’s largest 13C production cascade. After the complex build of phase one […]
Under a strategic partnership with Alamar Biosciences, Biognosys is a provider of choice of NULISA multiplex assay services for biopharma research The NULISAseq™ CNS Disease and Inflammation panels are now available for customers as a contract research service from Biognosys’ high-end proteomics facility in Europe By offering the combination of NULISA affinity-based assays and TrueDiscovery® mass […]
MOBILion Systems, Inc. said it appointed Rohit Khanna, Ph.D., to serve on its Board of Directors. Dr. Khanna is a life sciences executive with over three decades of experience in the analytical instrumentation industry, the company said in a statement. He previously co-founded software firm Dynamic Solutions and has held several leadership positions, it said. “Dr. […]
MILFORD, Mass. — Waters Corporation (NYSE:WAT) today announced the appointment of Heather Knight to its Board of Directors effective August 14, 2024. Ms. Knight currently serves as Executive Vice President and Group President, Medical Products and Therapies at Baxter International. Heather is an accomplished leader who brings decades of experience across the pharma and medical device […]
REDWOOD CITY, Calif. — Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced it has appointed Dr. Nicolas Roelofs to serve on its Board of Directors. “Nick is a fantastic addition to our board, bringing over 35 years of broad operational and advisory experience with leading […]
A Hiden Analytical cutting-edge HPR-20 EGA system, purchased by The Institute of Chemical Process Engineering at the Karlsruhe Institute of Technology (KIT) has recently been installed by Sachin Menon, our dedicated agent from Hiden Analytical Europe GmbH. This state-of-the-art equipment is set to transform research processes with its advanced capabilities in gas analysis. In a […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
